Swathi Pathadka

About

Clinical pharmacist with 7+ years of experience in HEOR/RWE studies using big medical databases across Asia (India, Hong Kong, and Japan). She has engaged with stakeholders across the APAC region, and successfully led workshops to improve access to healthcare in Thailand and Vietnam.

Employment

• Eli Lilly Services India Private Limited
  2022 - Present
• Ansea Consultants HEOR Consultant
  2021 - 2022
• Centre for Safe Medication Practice and Research Research Assistant
  2017 - 2021
• Kasturba Hospital Manipal
  2016 - 2017

Education

• Manipal College of Pharmaceutical Sciences PharmD
  2011 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Real-world data on patients with early breast cancer who were prescribed abemaciclib adjuvant therapy in Japan
  Future Oncology 2024 DOI: 10.1080/14796694.2024.2346464
  +Save
• Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study
  Diabetes Therapy 2024 DOI: 10.1007/s13300-024-01543-4
  +Save
• Prevalence of Metabolic Syndrome in Patients with Type 2 Diabetes in Japan: A Retrospective Cross-Sectional Study
  Diabetes Therapy 2024 DOI: 10.1007/s13300-023-01484-4
  +Save
• Barriers to breast cancer screening in Singapore: A literature review
  Annals of the Academy of Medicine, Singapore 2022 DOI: 10.47102/annals-acadmedsg.2021329
  +Save
• Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries
  Drugs 2022 DOI: 10.1007/s40265-022-01751-x
  +Save
• Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study
  BMJ Open 2022 DOI: 10.1136/bmjopen-2021-050510
  +Save
• Comparative efficacy and safety of statin and fibrate monotherapy: A systematic review and meta-analysis of head-to-head randomized controlled trials.
  PloS one 2021 DOI: 10.1371/journal.pone.0246480
  +Save
• Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study.
  Frontiers in cardiovascular medicine 2021 DOI: 10.3389/fcvm.2020.602363
  +Save
• Access and Unmet Needs of Orphan Drugs in 194 Countries and 6 Areas: A Global Policy Review With Content Analysis.
  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 DOI: 10.1016/j.jval.2020.06.020
  +Save
• Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study.
  Drug safety 2020 DOI: 10.1007/s40264-020-00961-0
  +Save